GSKH
Exchange-traded product on NYSE (US)
- Type
- Exchange-traded product
- Share class
- —
- Status
- listed
- ISIN
- —
- Currency
- —
- Represents the company
- No
Holdings as of Jun 30, 2026
The full portfolio as of the quarter end Jun 30, 2026, from the fund's report to the SEC (Form N-PORT, filed Aug 21, 2026), the newest we have: we do not read a daily file from this fund's website, or the filing is newer. Every line is listed: holdings we could identify link to their page, the rest (bonds, CLOs, loans, derivatives, securities we do not carry) are shown as filed, debt with its coupon and maturity; Shares is the principal amount for debt. Short positions are negative. Change is the share count against the filing of Mar 31, 2026.
3 lines, 1 linked, weights sum to 99.17% · Actively managed (N-CEN)
| Holding | Ticker / identifier | Type | Shares | Change | Weight | Market value |
|---|---|---|---|---|---|---|
| GSK PLC | GSK US37733W2044 | Equity | 13,617 | 0 | 96.79% | $ 713.803K |
|
DREYFUS TRSRY SECURITIES
|
Money market | 18,923.74 | −8,957.92 | 2.57% | $ 18.924K | |
|
CANADIAN IMPERIAL BANK OF COMMERCE CSWAP GBP VS USD
|
Swap short | 1 | 0 | -0.19% | $ -1,407.65 |